T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
University of Pennsylvania · Parker Institute for Cancer Immunotherapy · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,640
total citations
- FWCI
- 76.48
- Percentile
- 100%
- References
- 34
Citations per year
Authors
34- ACAlexander C. HuangCorresponding
University of Pennsylvania, Parker Institute for Cancer Immunotherapy
- MAMichael A. Postow
Memorial Sloan Kettering Cancer Center, Cornell University
- RJRobert J. Orlowski
University of Pennsylvania, Parker Institute for Cancer Immunotherapy
- RMRosemarie Mick
Parker Institute for Cancer Immunotherapy, University of Pennsylvania
- BBBertram Bengsch
Parker Institute for Cancer Immunotherapy, University of Pennsylvania
Topics & keywords
Topics
Keywords
- Pembrolizumab
- Blockade
- Medicine
- Immune system
- CD8
- Melanoma
- Immune checkpoint
- Immunotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.